Bausch Health Cos Property, Plant, and Equipment 2010-2024 | BHC

Bausch Health Cos property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
Bausch Health Cos Annual Property, Plant, and Equipment
(Millions of US $)
2023 $1,707
2022 $1,600
2021 $1,598
2020 $1,567
2019 $1,466
2018 $1,353
2017 $1,403
2016 $1,312
2015 $1,442
2014 $1,312
2013 $1,234
2012 $463
2011 $414
2010 $282
2009 $104
Bausch Health Cos Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-09-30 $1,789
2024-06-30 $1,738
2024-03-31 $1,713
2023-12-31 $1,707
2023-09-30 $1,584
2023-06-30 $1,599
2023-03-31 $1,596
2022-12-31 $1,600
2022-09-30 $1,507
2022-06-30 $1,545
2022-03-31 $1,579
2021-12-31 $1,598
2021-09-30 $1,584
2021-06-30 $1,590
2021-03-31 $1,556
2020-12-31 $1,567
2020-09-30 $1,550
2020-06-30 $1,496
2020-03-31 $1,450
2019-12-31 $1,466
2019-09-30 $1,390
2019-06-30 $1,372
2019-03-31 $1,341
2018-12-31 $1,353
2018-09-30 $1,341
2018-06-30 $1,355
2018-03-31 $1,411
2017-12-31 $1,403
2017-09-30 $1,398
2017-06-30 $1,373
2017-03-31 $1,328
2016-12-31 $1,312
2016-09-30 $1,462
2016-06-30 $1,472
2016-03-31 $1,466
2015-12-31 $1,442
2015-09-30 $1,351
2015-06-30 $1,360
2015-03-31 $1,335
2014-12-31 $1,312
2014-09-30 $1,300
2014-06-30 $1,320
2014-03-31 $1,215
2013-12-31 $1,234
2013-09-30 $1,222
2013-06-30 $441
2013-03-31 $453
2012-12-31 $463
2012-09-30 $450
2012-06-30 $409
2012-03-31 $427
2011-12-31 $414
2011-09-30 $356
2011-06-30 $319
2011-03-31 $308
2010-12-31 $282
2010-09-30 $280
2010-06-30 $96
2010-03-31 $107
2009-12-31 $104
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.009B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00